---
figid: PMC4834358__fonc-06-00085-g001
figtitle: Molecular pathways and targets of the epithelial–mesenchymal transition
organisms:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- Lareunionomyces loeiensis
- Triportheus paranensis
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
- Danio rerio
pmcid: PMC4834358
filename: fonc-06-00085-g001.jpg
figlink: /pmc/articles/PMC4834358/figure/F1/
number: F1
caption: Molecular pathways and targets of the epithelial–mesenchymal transition.
  (A) (1) One of the most well characterized EMT-inducing pathways is the transforming
  growth factor-β (TGF-β) family receptors capable of inducing PI3K–AKT, ERK MAPK,
  p38 MAPK, and JUN N-terminal kinase (JNK) pathways (activating pathways in blue;
  inactivating pathways in red). (2) The RAS–RAF–MEK–ERK MAPK pathway lies downstream
  of a number of growth factor activated receptor tyrosine kinases (RTKs) and activates
  a number of major EMT transcription factors (TFs). (3) Integrin signaling can have
  a multipronged effect on EMT by both interrupting critical epithelial adhesion molecules
  (e.g., E-cadherin) and antagonizing GSK3-β via the integrin-linked kinase (ILK)-AKT
  signaling, thus promoting EMT. (4) WNT signaling can also interfere with GSK3-β,
  thus stabilizing β-catenin to promote EMT transcriptional programs in cooperation
  with lymphoid enhancer-binding factor 1 (LEF1) and T-cell factor (TCF). (5) The
  Hedgehog (HH)-glioma 1 (GLI1) and (6) NOTCH pathway both can promote transcription
  of the EMT regulators. (7) Recently, a number of inflammatory pathways downstream
  of interleukin (IL) signaling (e.g., IL-6) have demonstrated the activation of the
  Janus-kinase (JAK)-signal transducer and activator of transcription 3 (STAT3) pathway,
  which in turn promotes EMT transcription factors. (8) Hypoxia is capable of activating
  a number of key components of EMT through the hypoxia-induced factor 1 (HIF1α).
  (B) Downstream of these signal transduction pathways leading to EMT are a variety
  of transcription factors with the ability to alter epithelial gene expression. As
  an epithelial plasticity program, many of the target genes altered include adhesion
  molecules. Known glycosylated proteins involved with EMT are denoted with an asterisk
  (*).
papertitle: Hijacking the Hexosamine Biosynthetic Pathway to Promote EMT-Mediated
  Neoplastic Phenotypes.
reftext: Kekoa Taparra, et al. Front Oncol. 2016;6:85.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9127855
figid_alias: PMC4834358__F1
figtype: Figure
redirect_from: /figures/PMC4834358__F1
ndex: 48a4e8ea-de92-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4834358__fonc-06-00085-g001.html
  '@type': Dataset
  description: Molecular pathways and targets of the epithelial–mesenchymal transition.
    (A) (1) One of the most well characterized EMT-inducing pathways is the transforming
    growth factor-β (TGF-β) family receptors capable of inducing PI3K–AKT, ERK MAPK,
    p38 MAPK, and JUN N-terminal kinase (JNK) pathways (activating pathways in blue;
    inactivating pathways in red). (2) The RAS–RAF–MEK–ERK MAPK pathway lies downstream
    of a number of growth factor activated receptor tyrosine kinases (RTKs) and activates
    a number of major EMT transcription factors (TFs). (3) Integrin signaling can
    have a multipronged effect on EMT by both interrupting critical epithelial adhesion
    molecules (e.g., E-cadherin) and antagonizing GSK3-β via the integrin-linked kinase
    (ILK)-AKT signaling, thus promoting EMT. (4) WNT signaling can also interfere
    with GSK3-β, thus stabilizing β-catenin to promote EMT transcriptional programs
    in cooperation with lymphoid enhancer-binding factor 1 (LEF1) and T-cell factor
    (TCF). (5) The Hedgehog (HH)-glioma 1 (GLI1) and (6) NOTCH pathway both can promote
    transcription of the EMT regulators. (7) Recently, a number of inflammatory pathways
    downstream of interleukin (IL) signaling (e.g., IL-6) have demonstrated the activation
    of the Janus-kinase (JAK)-signal transducer and activator of transcription 3 (STAT3)
    pathway, which in turn promotes EMT transcription factors. (8) Hypoxia is capable
    of activating a number of key components of EMT through the hypoxia-induced factor
    1 (HIF1α). (B) Downstream of these signal transduction pathways leading to EMT
    are a variety of transcription factors with the ability to alter epithelial gene
    expression. As an epithelial plasticity program, many of the target genes altered
    include adhesion molecules. Known glycosylated proteins involved with EMT are
    denoted with an asterisk (*).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Smo
  - Smox
  - Ptch1
  - Shh
  - Ilk
  - ras
  - Hras
  - Kras
  - Rem1
  - Pik3r1
  - Gsk3b
  - Zhx2
  - Traf6
  - Akt1
  - Mdk
  - Ctnnb1
  - Gli1
  - Hif1a
  - Ephb2
  - Mapk1
  - Nfkb1
  - Mapk8
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Itk
  - Slc22a3
  - Cdh1
  - Fzr1
  - Snai1
  - Snai2
  - Snai3
  - Twist1
  - Twist2
  - Cdh2
  - Acta2
  - Zeb1
  - Zeb2
  - TGFBR1
  - TGFBR2
  - TGFBR3
  - DHH
  - IHH
  - SHH
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - ITGA1
  - ITGA10
  - ITGA11
  - ITGA2
  - ITGA2B
  - ITGA3
  - ITGA4
  - ITGA5
  - ITGA6
  - ITGA7
  - ITGA8
  - ITGA9
  - ITGAD
  - ITGAE
  - ITGAL
  - ITGAM
  - ITGAV
  - ITGAX
  - ITGB1
  - ITGB2
  - ITGB3
  - ITGB4
  - ITGB5
  - ITGB6
  - ITGB7
  - ITGB8
  - ITGBL1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - SMO
  - SMOX
  - PTCH1
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - ILK
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - GSK3B
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - TRAF6
  - AKT1
  - AKT2
  - AKT3
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - CTNNB1
  - GLI1
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - HIF1A
  - EPHB2
  - MAPK1
  - MAPK3
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - MAPK14
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - HNF4A
  - ITK
  - SLC22A3
  - CDH1
  - FZR1
  - SNAI1
  - SNAI2
  - MUC2
  - SNAI3
  - TWIST1
  - TWIST2
  - CDH2
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - ACTA1
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - ZEB1
  - ZEB2
  - .na.character
  - scb
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - smo
  - sm
  - fz
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - sgg
  - Axn
  - gskt
  - Raf
  - Crtc
  - Akt
  - hop
  - bsk
  - Dsor1
  - Mtk
  - arm
  - Stat92E
  - sima
  - Erk7
  - rl
  - Dif
  - dl
  - Rel
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - pan
  - shg
  - sna
  - slug
  - CadN
  - Mmp1
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - ptch1
  - ptch2
  - shha
  - ilk
  - rab1ab
  - gsk3ba
  - traf6
  - ctnnb1
  - gli1
  - stat1b
  - stat4
  - hif1ab
  - mapk8b
  - mapk14a
  - elk4
  - cdh1
  - si:busm1-180o5.1
  - si:busm1-180o5.2
  - snai1a
  - snai2
  - snai3
  - cldn10e
  - twist1a
  - twist2
  - twist3
  - cdh2
  - zeb1b
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
